Letters of Interest (LOIs) for the 2021-2022 cycle are due by Friday, February 12, 2021.
The Coulter Program collaboratively works with UM faculty to develop medical device concepts invented at UM and license the related IP rights to medical device companies who complete development and seek FDA approvals.
The Coulter Program now requires an LOI prior to receiving an invitation to submit a project proposal. The Coulter Program has two award programs – Enlighten and Evolve.
Awardees receive direct mentoring from medical device industry experts and outside investors, market, regulatory and IP landscape assessments, and introductions to medical device companies. Program deliverables culminate with product strategic plans. Enlighten awardees will be invited to pitch for Evolve Awards to execute on strategic plans.
Uncover – New product design planning, early prototyping and verification studies.
Emerge –Advanced prototype development, FDA interactions, validation studies (bench, animal, human), and partnering meetings with medical device companies.